Covid vaccines: Transparency International flags evidence gaps
NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies | National Institute on Aging
A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one | PLOS ONE
The Evolution Of Clinical Trials: The Promise Of AI And The Role Of Big Tech
Trends, Charts, and Maps - ClinicalTrials.gov
Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer's Disease | Business Wire
Roche | What is a clinical trial and how does it work?
Step 3: Clinical Research | FDA
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature
Clinical Trial Randomization - NCI
Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers | The BMJ
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera™ for Treatment of Dry Eye
PDF) Press releases for Phase 2 clinical trial topline results: Have the objective pre-specified efficacy results been disclosed?
Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study) - eClinicalMedicine
ex99-1_017.jpg
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text
Phase III Trial Failures: Costly, But Preventable
10-Year Update on Study Results Submitted to ClinicalTrials.gov | NEJM
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension | Nature Medicine
Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS | Biogen
Keys to Successful Disclosure of Clinical Trial Data and Milestones
Downloading Content for Analysis - ClinicalTrials.gov
How to Find Results of Studies - ClinicalTrials.gov
Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) | npj Digital Medicine
